Esperion Therapeutics | ESPR - 股票

金融业

USD

USD 462.53M

现金及等价物

USD 156.16M

USD 27.85M

USD 459.46M

USD 300.36M

USD 262.92M

股息收益率

0

USD 85.23M

USD -9.93M

240

EPS每股收益

USD 0.26

股本和储备

USD -307.93M

USD 140.59M

债务利息支出

USD 22.64M

USD -0.15

USD 457.65M

USD 584M

USD 61.83M

USD 83.21M

USD 85.23M

普通股股本

USD 245.22M

129.79

USD 63.67M

USD 168.45M

销售和管理费用

USD 39.43M

USD 104.21M

贸易债权人

USD 68.41M

应收帐款人

USD 140.19M

	股票	更改		日
AbbVie	USD 5.05B		98M	2026-03
Alnylam Pharmaceuticals	USD 200.15M		117.43M	2026-03
Amarin	USD 183.58M		12.32M	2026-03
Amgen	USD 6.19B		39M	2026-03
Biogen	USD 1.95B		219.1M	2026-03
BioMarin Pharmaceutical	USD 1.27B		25.66M	2026-03
Cipla	INR 61.6B		5.18B	2025-09
CSL	USD 6.47B		327M	2025-06
Daiichi Sankyo	JPY 608.55B		93.64B	2025-09
Eli Lilly	USD 14.53B		785M	2026-03
Esperion Therapeutics	USD 104.21M		915K	2026-03
Geron	USD 133.29M		16.65M	2026-03
Grifols	EUR 3.56B		63.19M	2024-12
Halozyme Therapeutics	USD 155.47M		21.01M	2026-03
Heron Therapeutics	USD 54.57M		2.33M	2022-12
Ionis Pharmaceuticals	USD 5.56M		4.49M	2026-03
Merck	USD 6.48B		179M	2026-03
Moderna	USD 146M		7M	2026-03
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Pfizer	USD 10.67B		13M	2026-03
PTC Therapeutics	USD 75.57M		4.08M	2026-03
Puma Biotechnology	USD 9.48M		885K	2025-09
Regeneron Pharmaceuticals	USD 3.1B		97.2M	2026-03
Sanofi	EUR 22.69B		1.81B	2025-12
Sarepta Therapeutics	USD 1B		86.37M	2026-03
United Therapeutics	USD 178.3M		4.8M	2026-03
Vanda Pharmaceuticals	USD 1.85M		190K	2025-12